Besides, several researchers have predicted the therapeutic targets for diabetes and diabetic nephropathy, including TNF, TP53, PTGS2, MAPK1, AKT1, IL-6, JUN, and MMP9 [97–100]. Here, AKT1 is linked to diabetes mellitus.